NASDAQ
Evaxion Biotech A/S (EVAX) has a free cash flow growth of 0.00% as of Friday, May 29, 2026. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.